Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid for melasma
ACTRN12616000548437Phase 2Not yet recruiting
- Sponsor
- Dr Michelle Rodrigues
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tranexamic acid in melasma, sponsored by Dr Michelle Rodrigues. Planned start May 2016; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on ACTRN12616000548437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000548437.